iTraumaCare Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 13
  • Latest Deal Type
  • Crowdfunding
  • (Announced)
  • Latest Deal Amount
  • $8.94M
Latest Deal Amount
  • Investors
  • 1

iTraumaCare General Information


Developer of hemorrhage control system designed to control critical bleeding quickly during hemorrhage. The company's system provides a clamping device that works by sealing the skin closed to create a temporary pool of blood under pressure, which forms a stable clot until the wound can be surgically repaired, enabling physicians to treat common causes of preventable death in traumatic injury scenarios.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 1579 Monroe Drive
  • Suite F Unit 604
  • Atlanta, GA 30324
  • United States
+1 (210) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

iTraumaCare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Equity Crowdfunding $8.94M 0000 Announced Generating Revenue
5. Secondary Transaction - Private 0000 Completed Generating Revenue
4. Accelerator/Incubator 27-Apr-2015 0000 Completed Generating Revenue
3. Early Stage VC (Series B) 27-Jan-2014 00.00 0000 Completed Generating Revenue
2. Early Stage VC 26-Nov-2013 $3M $6.64M Completed Generating Revenue
1. Early Stage VC (Series A) 04-Dec-2012 $3.64M $3.64M Completed Generating Revenue
To view iTraumaCare’s complete valuation and funding history, request access »

iTraumaCare Executive Team (10)

Name Title Board Seat Contact Info
Joseph Brennan President, Chief Executive Officer & Board Member
Dennis Filips MD Co-Founder, President, Chief Medical Officer, Board Member & Vice Chairman
Ian Atkinson Ph.D Co-Founder, Chief Technology Officer & Board Member
Marvin Cervantes Director of Quality & Regulatory
Richard Waite Senior Director of Quality Assurance and Regulatory Affairs
You’re viewing 5 of 10 executive team members. Get the full list »

iTraumaCare Board Members (7)

Name Representing Role Since
Ian Atkinson Ph.D iTraumaCare Co-Founder, Chief Technology Officer & Board Member 000 0000
John Pinsent Self Board Member 000 0000
Paul Castella Ph.D Targeted Technology Board Member 000 0000
R. Stewart Thompson Self Executive Chairman 000 0000
Ruth Collins-Nakai Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

iTraumaCare Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iTraumaCare Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TEC Edmonton Accelerator/Incubator Minority 000 0000 000000 0
To view iTraumaCare’s complete investors history, request access »